Avadel Pharmaceuticals

8.76
0.16 (1.86%)
At close: Apr 25, 2025, 3:59 PM
8.77
0.17%
After-hours: Apr 25, 2025, 04:05 PM EDT

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending December 31, 2024, Avadel Pharmaceuticals generated $50.41M in revenue.
Revenue (ttm)
$169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
$899.56K
Employees
188
Market Cap
845.99M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 169.12M +504.79%
Dec 31, 2023 27.96M +Infinity%
Dec 31, 2022 0 n/a
Dec 31, 2021 0 -100.00%
Dec 31, 2020 22.33M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.